Delivery Order SPE2DB20D3103-SPE2DB22FN2J5
Award Date
4/4/22
Potential Completion Date
4/5/22
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,579.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, with a period of performance through January 3, 2025. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,389.47 delivery order is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, valued up to $999,999,999.00 through December 2025. The IDC enables DLA to efficiently procure a wide range of...
This federal contract award, valued at $1,462.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of December 13, 2024.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,203.54 Delivery Order contract is for the supply of the pharmaceutical product BARHEMSYS 10 MG/4 ML VIAL 4ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,118.90, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
The federal contract award is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024 with a ceiling value of $1,080.67. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a prescription medication. The firm-fixed-price contract, valued at $18,497.22, has a completion date of July 29, 2024. It does not have a set-aside designation. AmerisourceBergen, through its extensive supply chain capabilities, will provide this medication to support military treatment facilities and...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN4E3, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,237.80, is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The award does not have a set-aside designation, indicating it was competitively bid.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
The contract award is for the pharmaceutical product BARHEMSYS 5 MG/2 ML VIAL 2ML, with a ceiling value of $4,776.13. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,703.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for a prime vendor pharmaceutical supply delivery order, with an ultimate completion date of April 16, 2021. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...